The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Placental Stem Cell Therapy Market Research Report 2025
Synopsis
Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.
The global Placental Stem Cell Therapy market was valued at US$ 836 million in 2023 and is anticipated to reach US$ 1390.5 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Placental Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Placental Stem Cell Therapy.
Report Scope
The Placental Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Placental Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Placental Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics
Segment by Type
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others
Segment by Application
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placental Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Placental stem cells are cells derived from the placental blood and other body fluids of a new-born baby. Stem cells are human cells classified into a different variety of cell types, including brain and muscle cells. Stem cells are sometimes used in the development of regenerative therapies. Regenerative medicine represents a category of scientific alternatives to stem cell therapy (such as tissue regeneration). These treatments include the capacity to regenerate human cells, tissues, or organs to return the body to healthy working. Stem cell therapies are used to cure and improve diseases like spinal cord injuries, Parkinson's disease, heart disease, and diabetes.
The global Placental Stem Cell Therapy market was valued at US$ 836 million in 2023 and is anticipated to reach US$ 1390.5 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Placental Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Placental Stem Cell Therapy.
Report Scope
The Placental Stem Cell Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Placental Stem Cell Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Placental Stem Cell Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lifebank Stem Cell Banking
Cynata
Celularity
Athersys
Americord Registry
ReNeuron Group
ReeLabs
Mesoblast
Pluristem Therapeutics
Segment by Type
Hematologic Malignancies and Disorders
Congenital Immunodeficiency Disorders
Metabolic Disorders
Neurological Disorders
Others
Segment by Application
Hospitals and Specialty Clinics
Clinical Research Organizations
Research Institutes and Academies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Placental Stem Cell Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Placental Stem Cell Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hematologic Malignancies and Disorders
1.2.3 Congenital Immunodeficiency Disorders
1.2.4 Metabolic Disorders
1.2.5 Neurological Disorders
1.2.6 Others
1.3 Market by Application
1.3.1 Global Placental Stem Cell Therapy Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Specialty Clinics
1.3.3 Clinical Research Organizations
1.3.4 Research Institutes and Academies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Placental Stem Cell Therapy Market Perspective (2019-2030)
2.2 Placental Stem Cell Therapy Growth Trends by Region
2.2.1 Global Placental Stem Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Placental Stem Cell Therapy Historic Market Size by Region (2019-2024)
2.2.3 Placental Stem Cell Therapy Forecasted Market Size by Region (2025-2030)
2.3 Placental Stem Cell Therapy Market Dynamics
2.3.1 Placental Stem Cell Therapy Industry Trends
2.3.2 Placental Stem Cell Therapy Market Drivers
2.3.3 Placental Stem Cell Therapy Market Challenges
2.3.4 Placental Stem Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Placental Stem Cell Therapy Players by Revenue
3.1.1 Global Top Placental Stem Cell Therapy Players by Revenue (2019-2024)
3.1.2 Global Placental Stem Cell Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Placental Stem Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Placental Stem Cell Therapy Revenue
3.4 Global Placental Stem Cell Therapy Market Concentration Ratio
3.4.1 Global Placental Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Placental Stem Cell Therapy Revenue in 2023
3.5 Placental Stem Cell Therapy Key Players Head office and Area Served
3.6 Key Players Placental Stem Cell Therapy Product Solution and Service
3.7 Date of Enter into Placental Stem Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Placental Stem Cell Therapy Breakdown Data by Type
4.1 Global Placental Stem Cell Therapy Historic Market Size by Type (2019-2024)
4.2 Global Placental Stem Cell Therapy Forecasted Market Size by Type (2025-2030)
5 Placental Stem Cell Therapy Breakdown Data by Application
5.1 Global Placental Stem Cell Therapy Historic Market Size by Application (2019-2024)
5.2 Global Placental Stem Cell Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Placental Stem Cell Therapy Market Size (2019-2030)
6.2 North America Placental Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Placental Stem Cell Therapy Market Size by Country (2019-2024)
6.4 North America Placental Stem Cell Therapy Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Placental Stem Cell Therapy Market Size (2019-2030)
7.2 Europe Placental Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Placental Stem Cell Therapy Market Size by Country (2019-2024)
7.4 Europe Placental Stem Cell Therapy Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Placental Stem Cell Therapy Market Size (2019-2030)
8.2 Asia-Pacific Placental Stem Cell Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2019-2024)
8.4 Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Placental Stem Cell Therapy Market Size (2019-2030)
9.2 Latin America Placental Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Placental Stem Cell Therapy Market Size by Country (2019-2024)
9.4 Latin America Placental Stem Cell Therapy Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Placental Stem Cell Therapy Market Size (2019-2030)
10.2 Middle East & Africa Placental Stem Cell Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2019-2024)
10.4 Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lifebank Stem Cell Banking
11.1.1 Lifebank Stem Cell Banking Company Detail
11.1.2 Lifebank Stem Cell Banking Business Overview
11.1.3 Lifebank Stem Cell Banking Placental Stem Cell Therapy Introduction
11.1.4 Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.1.5 Lifebank Stem Cell Banking Recent Development
11.2 Cynata
11.2.1 Cynata Company Detail
11.2.2 Cynata Business Overview
11.2.3 Cynata Placental Stem Cell Therapy Introduction
11.2.4 Cynata Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.2.5 Cynata Recent Development
11.3 Celularity
11.3.1 Celularity Company Detail
11.3.2 Celularity Business Overview
11.3.3 Celularity Placental Stem Cell Therapy Introduction
11.3.4 Celularity Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.3.5 Celularity Recent Development
11.4 Athersys
11.4.1 Athersys Company Detail
11.4.2 Athersys Business Overview
11.4.3 Athersys Placental Stem Cell Therapy Introduction
11.4.4 Athersys Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.4.5 Athersys Recent Development
11.5 Americord Registry
11.5.1 Americord Registry Company Detail
11.5.2 Americord Registry Business Overview
11.5.3 Americord Registry Placental Stem Cell Therapy Introduction
11.5.4 Americord Registry Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.5.5 Americord Registry Recent Development
11.6 ReNeuron Group
11.6.1 ReNeuron Group Company Detail
11.6.2 ReNeuron Group Business Overview
11.6.3 ReNeuron Group Placental Stem Cell Therapy Introduction
11.6.4 ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.6.5 ReNeuron Group Recent Development
11.7 ReeLabs
11.7.1 ReeLabs Company Detail
11.7.2 ReeLabs Business Overview
11.7.3 ReeLabs Placental Stem Cell Therapy Introduction
11.7.4 ReeLabs Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.7.5 ReeLabs Recent Development
11.8 Mesoblast
11.8.1 Mesoblast Company Detail
11.8.2 Mesoblast Business Overview
11.8.3 Mesoblast Placental Stem Cell Therapy Introduction
11.8.4 Mesoblast Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.8.5 Mesoblast Recent Development
11.9 Pluristem Therapeutics
11.9.1 Pluristem Therapeutics Company Detail
11.9.2 Pluristem Therapeutics Business Overview
11.9.3 Pluristem Therapeutics Placental Stem Cell Therapy Introduction
11.9.4 Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2019-2024)
11.9.5 Pluristem Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Placental Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hematologic Malignancies and Disorders
Table 3. Key Players of Congenital Immunodeficiency Disorders
Table 4. Key Players of Metabolic Disorders
Table 5. Key Players of Neurological Disorders
Table 6. Key Players of Others
Table 7. Global Placental Stem Cell Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Placental Stem Cell Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Placental Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Placental Stem Cell Therapy Market Share by Region (2019-2024)
Table 11. Global Placental Stem Cell Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Placental Stem Cell Therapy Market Share by Region (2025-2030)
Table 13. Placental Stem Cell Therapy Market Trends
Table 14. Placental Stem Cell Therapy Market Drivers
Table 15. Placental Stem Cell Therapy Market Challenges
Table 16. Placental Stem Cell Therapy Market Restraints
Table 17. Global Placental Stem Cell Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Placental Stem Cell Therapy Market Share by Players (2019-2024)
Table 19. Global Top Placental Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy as of 2023)
Table 20. Ranking of Global Top Placental Stem Cell Therapy Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Placental Stem Cell Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Placental Stem Cell Therapy Product Solution and Service
Table 24. Date of Enter into Placental Stem Cell Therapy Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Placental Stem Cell Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Placental Stem Cell Therapy Revenue Market Share by Type (2019-2024)
Table 28. Global Placental Stem Cell Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Placental Stem Cell Therapy Revenue Market Share by Type (2025-2030)
Table 30. Global Placental Stem Cell Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Placental Stem Cell Therapy Revenue Market Share by Application (2019-2024)
Table 32. Global Placental Stem Cell Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Placental Stem Cell Therapy Revenue Market Share by Application (2025-2030)
Table 34. North America Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Placental Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Placental Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Placental Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Placental Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Placental Stem Cell Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Placental Stem Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Placental Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Placental Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Placental Stem Cell Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Placental Stem Cell Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 49. Lifebank Stem Cell Banking Company Detail
Table 50. Lifebank Stem Cell Banking Business Overview
Table 51. Lifebank Stem Cell Banking Placental Stem Cell Therapy Product
Table 52. Lifebank Stem Cell Banking Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 53. Lifebank Stem Cell Banking Recent Development
Table 54. Cynata Company Detail
Table 55. Cynata Business Overview
Table 56. Cynata Placental Stem Cell Therapy Product
Table 57. Cynata Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 58. Cynata Recent Development
Table 59. Celularity Company Detail
Table 60. Celularity Business Overview
Table 61. Celularity Placental Stem Cell Therapy Product
Table 62. Celularity Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 63. Celularity Recent Development
Table 64. Athersys Company Detail
Table 65. Athersys Business Overview
Table 66. Athersys Placental Stem Cell Therapy Product
Table 67. Athersys Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 68. Athersys Recent Development
Table 69. Americord Registry Company Detail
Table 70. Americord Registry Business Overview
Table 71. Americord Registry Placental Stem Cell Therapy Product
Table 72. Americord Registry Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 73. Americord Registry Recent Development
Table 74. ReNeuron Group Company Detail
Table 75. ReNeuron Group Business Overview
Table 76. ReNeuron Group Placental Stem Cell Therapy Product
Table 77. ReNeuron Group Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 78. ReNeuron Group Recent Development
Table 79. ReeLabs Company Detail
Table 80. ReeLabs Business Overview
Table 81. ReeLabs Placental Stem Cell Therapy Product
Table 82. ReeLabs Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 83. ReeLabs Recent Development
Table 84. Mesoblast Company Detail
Table 85. Mesoblast Business Overview
Table 86. Mesoblast Placental Stem Cell Therapy Product
Table 87. Mesoblast Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 88. Mesoblast Recent Development
Table 89. Pluristem Therapeutics Company Detail
Table 90. Pluristem Therapeutics Business Overview
Table 91. Pluristem Therapeutics Placental Stem Cell Therapy Product
Table 92. Pluristem Therapeutics Revenue in Placental Stem Cell Therapy Business (2019-2024) & (US$ Million)
Table 93. Pluristem Therapeutics Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Placental Stem Cell Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Placental Stem Cell Therapy Market Share by Type: 2023 VS 2030
Figure 3. Hematologic Malignancies and Disorders Features
Figure 4. Congenital Immunodeficiency Disorders Features
Figure 5. Metabolic Disorders Features
Figure 6. Neurological Disorders Features
Figure 7. Others Features
Figure 8. Global Placental Stem Cell Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Placental Stem Cell Therapy Market Share by Application: 2023 VS 2030
Figure 10. Hospitals and Specialty Clinics Case Studies
Figure 11. Clinical Research Organizations Case Studies
Figure 12. Research Institutes and Academies Case Studies
Figure 13. Others Case Studies
Figure 14. Placental Stem Cell Therapy Report Years Considered
Figure 15. Global Placental Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Placental Stem Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Placental Stem Cell Therapy Market Share by Region: 2023 VS 2030
Figure 18. Global Placental Stem Cell Therapy Market Share by Players in 2023
Figure 19. Global Top Placental Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Placental Stem Cell Therapy as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Placental Stem Cell Therapy Revenue in 2023
Figure 21. North America Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Placental Stem Cell Therapy Market Share by Country (2019-2030)
Figure 23. United States Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Placental Stem Cell Therapy Market Share by Country (2019-2030)
Figure 27. Germany Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Placental Stem Cell Therapy Market Share by Region (2019-2030)
Figure 35. China Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Placental Stem Cell Therapy Market Share by Country (2019-2030)
Figure 43. Mexico Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Placental Stem Cell Therapy Market Share by Country (2019-2030)
Figure 47. Turkey Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Placental Stem Cell Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Lifebank Stem Cell Banking Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 50. Cynata Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 51. Celularity Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 52. Athersys Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 53. Americord Registry Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 54. ReNeuron Group Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 55. ReeLabs Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 56. Mesoblast Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 57. Pluristem Therapeutics Revenue Growth Rate in Placental Stem Cell Therapy Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
